Figo Health
Software-enabled Namibian renal care provider. We give patients with CKD & ESRD better clinical outcomes.
The Opportunity
Chronic kidney disease (CKD) affects over 700 million people globally, in varying stages. End-stage renal disease (ESRD) is one of the main drivers of healthcare costs in developing and OECD countries - UK and USA spend annually over £1.4bn and $36bn respectively on ESRD patients. Reducing CKD cost burden by slowing CKD progression and outcome-driven dialysis is an incredible opportunity.
Figo Health slows CKD progression and aims to prevent patients from developing end-stage renal disease (ESRD). If patients do develop ESRD, we safely onboard patients onto our in-centre or at-home dialysis. Woven with software, continuous monitoring allows our clinical team to identify superior transplant candidates. Working with specialists, we guide the patient through their transplant program and ensure ongoing compliance.